Wednesday, 10 August 2022

INCOR Group forms JV with Renovis Pharma

27 June 2022 | News

To develop cost-effective and green technologies for the Indian and global pharma industry

Image Credit: Shutterstock

Image Credit: Shutterstock

Hyderabad-based conglomerate INCOR Group and Renovis Labs have entered into a new joint venture (JV) ‘INCOR Renovis’. The new company will focus on developing cost-effective and green technologies in the areas of human health, animal health and agriculture and will work towards making India self-reliant in manufacturing medicines under the AatmaNirbhar Bharat Abhiyan.
 
INCOR Renovis Pharma has come up with a new innovative methodology wherein it uses a combination of chemical, biological and engineering solutions to create high-quality, cheaper and safer medicines. The second major goal of the company is set out to achieve in its 10-year long-term plan of reducing carbon emissions associated with drug production and pharmaceutical development processes. The company plans to use automation in manufacturing to realise this vision and is in the process of filing numerous patents for its inventions and discoveries.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account